-
1دورية أكاديمية
المؤلفون: Huuhtanen, J. (Jani), Kasanen, H. (Henna), Peltola, K. (Katriina), Lönnberg, T. (Tapio), Glumoff, V. (Virpi), Brück, O. (Oscar), Dufva, O. (Olli), Peltonen, K. (Karita), Vikkula, J. (Johanna), Jokinen, E. (Emmi), Ilander, M. (Mette), Lee, M. H. (Moon Hee), Mäkelä, S. (Siru), Nyakas, M. (Marta), Li, B. (Bin), Hernberg, M. (Micaela), Bono, P. (Petri), Lähdesmäki, H. (Harri), Kreutzman, A. (Anna), Mustjoki, S. (Satu)
مصطلحات موضوعية: clinical medicine, immunology, oncology
وصف الملف: application/pdf
-
2دورية أكاديمية
المؤلفون: Ascierto, PA, Lipson, EJ, Dummer, R, Larkin, J, Long, GV, Sanborn, RE, Chiarion-Sileni, V, Dréno, B, Dalle, S, Schadendorf, D, Callahan, MK, Nyakas, M, Atkinson, V, Gomez-Roca, CA, Yamazaki, N, Tawbi, HA, Sarkis, N, Warad, D, Dolfi, S, Mitra, P, Suryawanshi, S, Grob, J-J
المساهمون: Larkin, James
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; application/pdf
العلاقة: Journal of Clinical Oncology, 2023, pp. JCO2202072 -; https://repository.icr.ac.uk/handle/internal/5779Test
الإتاحة: https://doi.org/10.1200/JCO.22.02072Test
https://repository.icr.ac.uk/handle/internal/5779Test -
3دورية أكاديمية
المؤلفون: Piperno-Neumann, S., Carlino, M. S., Boni, V., Loirat, D., Speetjens, F. M., Park, J. J., Calvo, E., Carvajal, R. D., Nyakas, M., Gonzalez-Maffe, J., Zhu, X., Shirley, M. D., Ramkumar, T., Fessehatsion, A., Burks, H. E., Yerramilli-Rao, P., Kapiteijn, E.
المساهمون: Novartis Pharmaceuticals Corporation
المصدر: British Journal of Cancer ; volume 128, issue 6, page 1040-1051 ; ISSN 0007-0920 1532-1827
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1038/s41416-022-02133-6Test
https://www.nature.com/articles/s41416-022-02133-6.pdfTest
https://www.nature.com/articles/s41416-022-02133-6Test -
4دورية أكاديمية
المؤلفون: Aamdal, E., Skovlund, E., Jacobsen, K.D., Straume, O., Kersten, C., Herlofsen, O., Karlsen, J., Hussain, I., Amundsen, A., Dalhaug, A., Nyakas, M., Hagene, K.T., Holmsen, K., Aamdal, S., Kaasa, S., Guren, T.K., Kyte, J.A.
المصدر: ESMO Open ; volume 7, issue 5, page 100588 ; ISSN 2059-7029
مصطلحات موضوعية: Cancer Research, Oncology
الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100588Test
https://api.elsevier.com/content/article/PII:S2059702922002186?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2059702922002186?httpAccept=text/plainTest -
5دورية أكاديميةMelanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
المؤلفون: Bhave, P, Pallan, L, Long, GV, Menzies, AM, Atkinson, V, Cohen, JV, Sullivan, RJ, Chiarion-Sileni, V, Nyakas, M, Kahler, K, Hauschild, A, Plummer, R, Trojaniello, C, Ascierto, PA, Zimmer, L, Schadendorf, D, Allayous, C, Lebbe, C, Maurichi, A, Santinami, M, Roy, S, Robert, C, Lesimple, T, Patel, S, Versluis, JM, Blank, CU, Khattak, A, Van der Westhuizen, A, Carlino, MS, Shackleton, M, Haydon, A
العلاقة: pii: 10.1038/s41416-020-01121-y; Bhave, P., Pallan, L., Long, G. V., Menzies, A. M., Atkinson, V., Cohen, J. V., Sullivan, R. J., Chiarion-Sileni, V., Nyakas, M., Kahler, K., Hauschild, A., Plummer, R., Trojaniello, C., Ascierto, P. A., Zimmer, L., Schadendorf, D., Allayous, C., Lebbe, C., Maurichi, A. ,. Haydon, A. (2021). Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis. Br J Cancer, 124 (3), pp.574-580. https://doi.org/10.1038/s41416-020-01121-yTest.; http://hdl.handle.net/11343/304521Test
-
6دورية أكاديمية
المؤلفون: Shoushtari, A.N., Olszanski, A.J., Nyakas, M., Hornyak, T.J., Wolchok, J.D., Levitsky, V., Møller, A-S., Kuryk, L., Risberg Handeland, K., Jäderberg, M.
المصدر: Annals of Oncology ; volume 32, page S897-S898 ; ISSN 0923-7534
مصطلحات موضوعية: Oncology, Hematology
الإتاحة: https://doi.org/10.1016/j.annonc.2021.08.1468Test
https://api.elsevier.com/content/article/PII:S0923753421036978?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0923753421036978?httpAccept=text/plainTest -
7مؤتمر
المؤلفون: Heiberg, M., Syversen, S. W., Irgens, K., Bitter, H., Bakland, G., Nyakas, M., Ødegård, H., Vestaby, H., Knutsen, I. L., Bergsmark, K., Haavardsholm, E. A., Mjaavatten, M. D.
المصدر: Scientific Abstracts
-
8دورية أكاديمية
المؤلفون: Ny, L. (L.), Hernberg, M. (M.), Nyakas, M. (M.), Koivunen, J. (J.), Oddershede, L. (L.), Yoon, M. (M.), Wang, X. (X.), Guyot, P. (P.), Geisler, J. (J.)
وصف الملف: application/pdf
-
9دورية أكاديمية
المؤلفون: Jansen, Y. J. L., Rozeman, E. A., Mason, R., Goldinger, S. M., Foppen, M. H. Geukes, Hoejberg, L., Schmidt, H., van Thienen, J., Haanen, J. B. A. G., Tiainen, L., Svane, I. M., Mäkelä, S., Seremet, T., Arance, A., Dummer, R., Bastholt, L., Nyakas, M., Straume, O., Menzies, A. M., Long, G., Atkinson, Jeffrey, Blank, C. U., Neyns, B.
المساهمون: HUS Comprehensive Cancer Center, Department of Oncology, University of Helsinki
مصطلحات موضوعية: melanoma, anti-PD-1 therapy, duration of treatment, immunotherapy, COMBINED NIVOLUMAB, SURVIVAL, PEMBROLIZUMAB, IPILIMUMAB, MONOTHERAPY, PROFILE, SAFETY, 3122 Cancers
وصف الملف: application/pdf
العلاقة: Jansen , Y J L , Rozeman , E A , Mason , R , Goldinger , S M , Foppen , M H G , Hoejberg , L , Schmidt , H , van Thienen , J , Haanen , J B A G , Tiainen , L , Svane , I M , Mäkelä , S , Seremet , T , Arance , A , Dummer , R , Bastholt , L , Nyakas , M , Straume , O , Menzies , A M , Long , G , Atkinson , J , Blank , C U & Neyns , B 2019 , ' Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity : clinical outcomes in advanced melanoma ' , Annals of Oncology , vol. 30 , no. 7 , pp. 1154-1161 . https://doi.org/10.1093/annonc/mdz110Test; ea02842f-2f3b-4341-a3be-9d44ae4ffa41; http://hdl.handle.net/10138/310955Test; 000484369900022
-
10دورية أكاديمية
المؤلفون: Hauschild, A, Dummer, R, Schadendorf, D, Santinami, M, Atkinson, V, Mandalà, M, Chiarion-Sileni, V, Larkin, J, Nyakas, M, Dutriaux, C, Haydon, A, Robert, C, Mortier, L, Schachter, J, Lesimple, T, Plummer, R, Dasgupta, K, Haas, T, Shilkrut, M, Gasal, E, Kefford, R, Kirkwood, JM, Long, GV
المساهمون: Larkin, James
مصطلحات موضوعية: Humans, Melanoma, Skin Neoplasms, Oximes, Imidazoles, Pyridones, Pyrimidinones, Proto-Oncogene Proteins B-raf, Antineoplastic Combined Chemotherapy Protocols, Adjuvants, Immunologic, Disease-Free Survival, Treatment Outcome, Drug Administration Schedule, Follow-Up Studies, Double-Blind Method, Age Factors, Sex Factors, Dose-Response Relationship, Drug, Time Factors, Internationality, Adult, Middle Aged, Female, Male
وصف الملف: Print-Electronic; 3449; application/pdf
العلاقة: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 36 (35), pp. 3441 - 3449; https://repository.icr.ac.uk/handle/internal/4144Test
الإتاحة: https://doi.org/10.1200/jco.18.01219Test
https://repository.icr.ac.uk/handle/internal/4144Test